Community Oncology Services Global Market Report 2025

Community Oncology Services involve specialized healthcare delivered in local settings aimed at the prevention, diagnosis, treatment, and management of cancer, primarily through local oncology practices and clinics. The primary objective is to provide accessible and comprehensive cancer care that is customized for individual patients, which includes coordinated treatment plans and supportive services. By offering care within the community, these services aim to enhance patient outcomes and quality of life while reducing travel burdens for patients and their families.

Primary types of community oncology services are small, medium, and large clinics. Small clinics typically consist of a single oncologist, one office, and a support staff including physician extenders, nurses, pharmacists, pharmacy technicians, and others. Cancers treated include breast, lung, kidney, liver, ovarian, prostate, skin, pancreatic, blood, colorectal, and others, involving therapies such as medical oncology, radiation oncology, surgical oncology, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The community oncology services market research report is one of a series of new reports from The Business Research Company that provides community oncology services market statistics, including community oncology services industry global market size, regional shares, competitors with a community oncology services market share, detailed community oncology services market segments, market trends and opportunities, and any further data you may need to thrive in the community oncology services industry. This community oncology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The community oncology services market size has grown strongly in recent years. It will grow from $50.54 billion in 2024 to $54.25 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increased healthcare expenditure, rapid growth in the elderly population, and health insurance reforms.

The community oncology services market size is expected to see strong growth in the next few years. It will grow to $74.67 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, changing lifestyles, and increasing investments in healthcare infrastructures. Major trends in the forecast period include a focus on providing telehealth services, partnerships and collaborations, developing individualized service plans, technological advancements, and mergers and acquisitions.

The forecast of 8.3% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. cancer care by driving up the cost of infusion pumps and oral chemotherapy dispensing systems sourced from Switzerland and the Netherlands, exacerbating rural oncology access challenges and increasing practice overheads. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The demand for community oncology services is expected to surge due to the cost-effectiveness offered by these centers compared to hospital-based care. Community oncology centers provide cancer care services at a notably lower cost per patient per month than hospital-based clinics, as revealed in a report by the Community Oncology Alliance. The cost of cancer care, including chemotherapy treatment, in community-based clinics proves to be significantly more affordable, approximately $12,000 per patient per month compared to about $20,000 in hospital-based oncology clinics. This cost discrepancy is anticipated to fuel the growth of the community oncology services market in the foreseeable future.

The growth of the community oncology services market is further propelled by the increasing demand for chemotherapy treatments. Chemotherapy, a systemic cancer treatment targeting rapidly dividing cells, remains a crucial aspect of cancer care, necessitating comprehensive oncology services. With the rising need for chemotherapy expected to escalate from 10 million to 15 million by 2040, as reported by Healthcare IT News in February 2022, the significance of oncology services in providing comprehensive care is evident. This surge in chemotherapy demand is a significant driver of growth for the community oncology services market.

Major corporations in the community oncology services sector are actively engaging in acquisitions and research collaborations to broaden their service portfolios and offerings. In April 2023, TPG, a US-based private equity firm, and AmerisourceBergen Corporation, a US-based wholesaler, jointly acquired OneOncology for a sum of 2.1 billion dollars. This acquisition reinforces TPG and AmerisourceBergen's foothold in the specialty practice network and augments their solutions within the oncology realm. OneOncology, a US-based entity, focuses on revolutionizing the patient experience while addressing the challenges encountered in community oncology, positioning itself as a leader in cancer care advancement.

Prominent entities in the community oncology services sector are significantly investing in cancer drugs to fortify the battle against cancer. These corporate investments in oncology services serve as a crucial link between delivering high-quality cancer care and sustainable healthcare solutions. Notably, in March 2023, Pfizer, a US-based pharmaceutical powerhouse, merged with Seagen, a US-based biotechnology company, and committed an investment of $43 billion to combat cancer. This strategic move bolsters Pfizer's presence in the oncology domain, intensifying the fight against cancer, a prominent global cause of mortality.

In September 2023, American Oncology Network, LLC (AON), a US-based network of community oncology practices, formed a partnership with Digital Transformation Opportunities Corp. This collaboration aims to incorporate new providers into the AON network, scale ancillary services, and expand current offerings to meet the needs of the broader oncology market. Digital Transformation Opportunities Corp. is a US-based company that specializes in the healthcare sector.

Major companies operating in the community oncology services market include The US Oncology Network, OneOncology, Florida Cancer Specialists & Research Institute (FCS), The Oncology Institute, Community Care Physicians, P.C. (CCP), GenesisCare, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Nanjing Legend Pharmaceutical & Chemical Co., Ltd, Zai Labare, Taxane HealthCare Pvt Ltd, Getwell Oncology, Novartis Oncology, Celgene, Johnson & Johnson, Janssen Pharma, Pharmacyclics, Healthkind Labs Pvt Ltd, Arlak Biotech, SwisscheM Healthcare Pvt Ltd, Apikos Pharma, Kolaz Biotech, Quironsalud Proton Therapy Centre, The London Clinic England, Institut Gustave Roussy, Netherlands Cancer Institute, European Medical Center, Yauza Medical Center, Celon Pharma, Nebraska Cancer Specialists, Tufts Medical Center, Doctors Medical Center, Oncology Specialists SC, Baptist Cancer Center, Mayo Clinic, Cleveland Clinic, Fred Hutchinson Cancer Research Center, The University of Texas Southwestern Medical Center, Abramson Cancer Center, McKesson Corporation, TUTEUR Argentina, Takeda Pharmaceutical Company Limited, Pierre Fabre Group, Celnova Pharma, King Hussein Cancer Center (KHCC), Princess Noorah Oncology Center (PNOC), King Abdulaziz Medical City, King Faisal Specialist Hospital and Research Centre, King Fahd Specialist Hospital, Prince Sultan Medical Military City, King Saud Medical City, King Abdullah Medical City, Tawam Hospital, Icon Oncology, Eurolab Science Laboratuvar, Yemaachi Biotechnology, Regal Pharmaceuticals Limited, Ocean Road Cancer Institute

North America was the largest region in the community oncology services market in 2024. Western Europe was the second largest region in the global oncology services market. The regions covered in the community oncology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the community oncology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The community oncology services market includes revenues earned by entities by providing diagnostic, corrective and preventive treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Community Oncology Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on community oncology services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for community oncology services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The community oncology services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics
• 2) By Cancer Type: Breast Cancer, Lung Cancer, Kidney Cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Blood Cancer, Colorectal Cancer, Other Cancer Types
• 3) By Therapy Type: Medical Oncology, Radiation Oncology, Surgical Oncology, Other Therapies
• Subsegments:
• 1) By Small Community Oncology Clinics: Independent Oncology Practices; Single-Physician Oncology Offices; Community-Based Cancer Screening and Prevention Services
• 2) By Medium Community Oncology Clinics: Multi-Physician Oncology Practices; Integrated Community Cancer Centers; Outpatient Treatment Facilities; Community-Based Clinical Trials
• 3) By Large Community Oncology Clinics: Comprehensive Cancer Centers; Academic-affiliated Community Oncology Practices; Multi-disciplinary Treatment Centers; Specialized Oncology Services
• Companies Mentioned: The US Oncology Network; OneOncology; Florida Cancer Specialists & Research Institute (FCS); The Oncology Institute; Community Care Physicians, P.C. (CCP); GenesisCare; CStone Pharma; CARsgen Therapeutics; JW Therapeutics; BeiGene; Nanjing Legend Pharmaceutical & Chemical Co., Ltd; Zai Labare; Taxane HealthCare Pvt Ltd; Getwell Oncology; Novartis Oncology; Celgene; Johnson & Johnson; Janssen Pharma; Pharmacyclics; Healthkind Labs Pvt Ltd; Arlak Biotech; SwisscheM Healthcare Pvt Ltd; Apikos Pharma; Kolaz Biotech; Quironsalud Proton Therapy Centre; The London Clinic England; Institut Gustave Roussy; Netherlands Cancer Institute; European Medical Center; Yauza Medical Center; Celon Pharma; Nebraska Cancer Specialists; Tufts Medical Center; Doctors Medical Center; Oncology Specialists SC; Baptist Cancer Center; Mayo Clinic; Cleveland Clinic; Fred Hutchinson Cancer Research Center; The University of Texas Southwestern Medical Center; Abramson Cancer Center; McKesson Corporation; TUTEUR Argentina; Takeda Pharmaceutical Company Limited; Pierre Fabre Group; Celnova Pharma; King Hussein Cancer Center (KHCC); Princess Noorah Oncology Center (PNOC); King Abdulaziz Medical City; King Faisal Specialist Hospital and Research Centre; King Fahd Specialist Hospital; Prince Sultan Medical Military City; King Saud Medical City; King Abdullah Medical City; Tawam Hospital; Icon Oncology; Eurolab Science Laboratuvar; Yemaachi Biotechnology; Regal Pharmaceuticals Limited; Ocean Road Cancer Institute
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.